Jamal Rana MD FACC/LinkedIn
Nov 11, 2025, 23:38
The Wall Street Journal Features Major AHA Trials on Cholesterol Breakthroughs
Jamal Rana, Professor in the Department of Clinical Science at Kaiser Permanente Bernard J. Tyson School of Medicine, posted on LinkedIn:
”Many reached out requesting access to read the full article. The story made it to the print version, given this was The Wall Street Journal’s main coverage of the biggest trials presented at AHA Scientific Sessions 2025. We are now in era where multiple options exist to aggressively treat LDL cholesterol in high-risk patients to prevent heart disease.
Link here.”
Stay updated with Hemostasis Today.
AHA
American College of Cardiology
American Heart Association
Atherosclerosis
Betsy McKay
Cardiology
Cholesterol
European Atherosclerosis Society
Health
Heart Disease
Heart Health
Hematology
Hemostasis
Hemostasis Today
Jamal Rana
Kaiser Permanente Bernard J. Tyson School of Medicine
Medicine
The Wall Street Journal
thrombosis
-
Dec 15, 2025, 15:58Khaled Musallam Applauds Hatoon Ezzat’s Leadership and Healthcare Advances in Saudi Arabia
-
Dec 15, 2025, 12:46Deborah Ebert Long on Hemophilia Care: Progress, Possibility, and the Power of Listening
-
Dec 15, 2025, 12:34Nathan Connell on Conversion from Eptacog Alfa to Beta
-
Dec 15, 2025, 12:17Danny Hsu on Interdisciplinary Toolkit for Gynecologic Bleeding on Anticoagulation
-
Dec 15, 2025, 12:08Ted Roh: A Historic Milestone for Indonesia’s Health Innovation
-
Dec 15, 2025, 11:28Wolfgang Miesbach Shares Insights from Davide Matino’s Presentation on Marstacimab at ASH25
-
Dec 15, 2025, 11:12Tushar Pandey Awarded for His Enourmous Contribution to Hematology
-
Dec 15, 2025, 11:07DISTRO: Vidya Rajbhoj on AI and Digital Technology to Improve Stroke Rehabilitation
-
Dec 15, 2025, 11:00Ischemic Stroke, AF and Atherosclerotis: Amira Khater on Sufficiency of Anticoagulant Monotherapy